in view of this limitation in antimicrobial therapy , enoxacin , a second-generation quinolone , has been assessed in vitro against resistant and other organisms , and its breakpoint sensitivity has been compared with another quinolone , ofloxacin .
C1136254
antimicrobial
C0028902
ofloxacin